Delaware | 4911 | 823168838 |
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification No.) |
Ryan J. Maierson Nick S. Dhesi John J. Slater Latham & Watkins LLP 811 Main Street, Suite 3700 Houston, Texas 77002 (713) 546-5400 | Sarah K. Morgan Jackson A. O’Maley Alexandra M. Lewis Vinson & Elkins L.L.P. 845 Texas Avenue, Suite 4700 Houston, Texas 77002 (713) 758-2222 |
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
Emerging growth company | ☒ |


Per Share | Total | ||
Initial public offering price .............................................................................................................................................................. | $ | $ | |
Underwriting discounts and commissions(1) ..................................................................................................................................... | $ | $ | |
Proceeds, before expenses, to us ...................................................................................................................................................... | $ | $ |
J.P. Morgan | BofA Securities | RBC Capital Markets | Barclays |
Baird | BBVA | Guggenheim Securities | MUFG |
Societe Generale | William Blair | Piper Sandler | Wolfe | Nomura Alliance |



Page | |
Letter from Tim Latimer, Chief Executive Officer ........................................................................................... | |
Prospectus Summary ......................................................................................................................................... | |
The Offering ...................................................................................................................................................... | |
Market and Industry Data ................................................................................................................................. | |
Estimates of Capacity Potential ........................................................................................................................ | |
Cautionary Note Regarding Forward-Looking Statements .............................................................................. | |
Risk Factors ...................................................................................................................................................... | |
Use of Proceeds ................................................................................................................................................. | |
Dividend Policy ................................................................................................................................................ | |
Capitalization .................................................................................................................................................... | |
Dilution ............................................................................................................................................................. | |
Management's Discussion and Analysis of Financial Condition and Results of Operations ........................... | |
Business ............................................................................................................................................................ | |
Management ...................................................................................................................................................... | |
Executive and Director Compensation ............................................................................................................. | |
Principal Stockholders ...................................................................................................................................... | |
Certain Relationships and Related Party Transactions ..................................................................................... | |
Description of Capital Stock ............................................................................................................................. | |
Shares Eligible for Future Sale ......................................................................................................................... | |
Material U.S. Federal Income Tax Considerations for Non-U.S. Holders of Common Stock ........................ | |
Underwriting ..................................................................................................................................................... | |
Legal Matters .................................................................................................................................................... | |
Experts .............................................................................................................................................................. | |
Where You Can Find More Information .......................................................................................................... | |








Class A common stock offered by us ................ | 70,000,000 shares (or 80,500,000 shares if the underwriters exercise their option to purchase additional shares of Class A common stock from us in full). | |
Underwriters’ option to purchase additional shares of Class A common stock ................... | The underwriters have an option to purchase up to 10,500,000 additional shares of Class A common stock from us at the initial public offering price, less the underwriting discounts and commissions. The underwriters can exercise this option at any time within 30 days from the date of this prospectus. | |
Class A common stock to be outstanding after this offering .................................................... | 275,776,919 shares (or 286,276,919 shares if the underwriters exercise their option to purchase additional shares of Class A common stock in full). | |
Class B common stock to be outstanding after this offering .................................................... | 7,785,414 shares. | |
Total Class A and Class B common stock to be outstanding immediately after this offering .......................................................... | 283,562,333 shares (or 294,062,333 shares if the underwriters exercise their option to purchase additional shares of Class A common stock in full). | |
Voting power of Class A common stock after giving effect to this offering .......................... | 46.97% (or 47.90% if the underwriters exercise their option to purchase additional shares of Class A common stock in full). | |
Voting power of Class B common stock after giving effect to this offering .......................... | 53.03% (or 52.10% if the underwriters exercise their option to purchase additional shares of Class A common stock in full). | |
Use of proceeds ................................................. | We estimate that we will receive net proceeds from this offering of approximately $1,668,696,700 (or approximately $1,920,381,700 if the underwriters exercise in full their option to purchase additional shares of Class A common stock), based upon an assumed initial public offering price of $25.50 per share (which is the midpoint of the price range set forth on the cover page of this prospectus) and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The principal purposes of this offering are to increase our capitalization and financial flexibility, create a public market for our Class A common stock, and enable access to the public equity markets for us and our Class A common stockholders. We intend to use the net proceeds from this offering for general corporate purposes, including project-level capital expenditures, continued development of our GeoClusters and portfolio of land holdings, working capital and operating expenses. Pending identification of specific uses, our priority is capital expenditures, continued development of our GeoClusters and portfolio of land holdings, then working capital and operating expenses, and a significant portion is not currently allocated; accordingly we cannot estimate amounts for each use. We will have broad discretion in the way that we use the net proceeds of this offering. If proceeds are less than expected, we will prioritize working capital and operating expenses. See “Use of Proceeds.” | |
Voting rights ...................................................... | Upon completion of this offering, we will have two classes of common stock outstanding: Class A common stock and Class B common stock. The rights of the holders of our Class A common stock and Class B common stock are identical, except with respect to voting, conversion and transfer rights. Each share of our Class A common stock is entitled to one vote per share. Each share of our Class B common stock is entitled to 40 votes per share. Holders of shares of our Class A common stock and Class B common stock will generally vote together as a single class, unless otherwise required by law or our Amended Charter that becomes effective immediately prior to the completion of this offering. Each share of our Class B common stock is convertible into one share of our Class A common stock at any time at the election of the holder and will convert automatically upon any transfer, except for permitted transfers, described in our Amended Charter, including transfers to immediate family members (including upon Mr. Latimer’s or Dr. Norbeck’s death), trusts (including grantor retained annuity trusts) for which the stockholder or their immediate family member serves as trustee, and partnerships, corporations, and other entities exclusively owned by Mr. Latimer or Dr. Norbeck or either of their immediate families, and upon the earliest to occur of (i) the first trading day following the seventh anniversary of this offering, (ii) the date on which the number of shares of Class A and Class B common stock beneficially owned by Mr. Latimer’s and Dr. Norbeck’s permitted transferees (including shares underlying outstanding options) represents less than 25% of the shares of Class A and Class B common stock beneficially owned by Mr. Latimer and Dr. Norbeck, in the aggregate, on the closing date of this offering, (iii) the death or disability of a Co-Founder, and (iv) the termination of a Co- Founder for cause. | |
Immediately following the completion of this offering, and assuming no exercise of the underwriters’ option to purchase additional shares to cover over-allotments, if any, and assuming Mr. Latimer and Dr. Norbeck do not purchase any shares of Class A common stock pursuant to the reserved share program, Mr. Latimer and Dr. Norbeck will beneficially own, in the aggregate, approximately 53.03% of the voting power of our outstanding capital stock. As a result, Mr. Latimer and Dr. Norbeck will have significant influence over the outcome of matters submitted to our stockholders for approval, including the election of our directors and the approval of any change of control transaction. These risks are more fully described in the section titled “Risk Factors.” Additional information can be found in the sections titled “Principal Stockholders” and “Description of Capital Stock.” | ||
Indication of Interest ......................................... | Atlas Point Energy Infrastructure Fund, LLC, Norges Bank Investment Management, a division of Norges Bank, Wellington Management, and one or more funds and/or accounts managed by Capital Research Global Investors (collectively, the “Cornerstone Investors”) have, severally and not jointly, indicated an interest in purchasing up to an aggregate of $350 million in shares of our Class A common stock in this offering at the initial public offering price and on the same terms and conditions as the other purchasers in this offering. The shares of Class A common stock to be purchased by the Cornerstone Investors will not be subject to a lock-up agreement with the underwriters. Because this indication of interest is not a binding agreement or commitment to purchase, the Cornerstone Investors may determine to purchase more, fewer, or no shares in this offering, or the underwriters may determine to sell more, fewer, or no shares to the Cornerstone Investors. The underwriters will receive the same underwriting discount on any shares of our Class A common stock purchased by the Cornerstone Investors as they will from the other shares sold to the public in this offering. | |
Dividend policy ................................................. | We have no current plans to pay dividends on our common stock following this offering. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our board of directors may deem relevant. Because we are a holding company and have no direct operations, we will only be able to pay dividends from funds we receive from our subsidiaries. Certain of our subsidiaries are party to project-level financing arrangements that contractually restrict or prioritize cash distributions before any amounts can be upstreamed to us. In addition, our ability to pay dividends is limited by the Credit Agreement, which contains negative covenants that generally prohibit us and our subsidiaries from making “Restricted Payments,” including dividends and other distributions, subject to only limited exceptions for certain subsidiary distributions that meet specified conditions, and may be limited by the agreements governing any indebtedness we or our subsidiaries may incur in the future. See “Dividend Policy.” | |
Reserved share program .................................... | At our request, an affiliate of BofA Securities, Inc., a participating underwriter, has reserved for sale, at the initial public offering price, up to 5% of the shares of Class A common stock to be issued by us and offered by the prospectus for sale to some of our directors, officers and employees and related persons. If these persons purchase reserved shares it will reduce the number of shares available for sale to the general public. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same basis as the other shares offered by this prospectus. See “Underwriting—Reserved Share Program.” | |
Risk factors ........................................................ | ||
Proposed trading symbol ................................... | We intend to apply to list our Class A common stock on the NASDAQ under the symbol “FRVO.” |
(In thousands, except share and per share data) | Year ended December 31, | ||
2025 | 2024 | ||
Consolidated Statements of Operations | |||
Revenues ................................................................................................................... | $138 | $199 | |
Costs and expenses: | |||
Operation and maintenance ................................................................................. | 388 | 380 | |
Research and development income, net ................................................................ | (133) | (97) | |
General and administrative expenses ................................................................... | 38,718 | 34,735 | |
Operating lease expenses ..................................................................................... | 9,681 | 6,895 | |
Depreciation and amortization .............................................................................. | 290 | 124 | |
Operating loss ................................................................................................. | (48,806) | (41,838) | |
Other income (expense): | |||
Interest income ..................................................................................................... | 4,192 | 1,787 | |
Interest expense .................................................................................................... | (8,406) | (766) | |
Other non-operating expense ................................................................................ | (4,767) | (237) | |
Loss before income taxes ........................................................................................ | (57,787) | (41,054) | |
Income tax expense ............................................................................................... | (1) | (56) | |
Net loss ..................................................................................................................... | $(57,788) | $(41,110) | |
Net loss .................................................................................................................... | $(57,788) | $(41,110) | |
Less: Remeasurement of redeemable noncontrolling interest ............................... | (12,727) | — | |
Net loss attributable to common shares, basic and diluted ................................... | $(70,515) | $(41,110) | |
Weighted average shares, basic and diluted ............................................................ | 12,462 | 12,438 | |
Net loss per share attributable to common stockholders, basic and diluted ........ | $(5.66) | $(3.31) | |
Weighted-average shares used in computing adjusted net income per share, basic and diluted (1) .......................................................................................................... | 212,948 | 212,931 | |
Adjusted net loss per share, basic and diluted(1) ................................................... | $(0.33) | $(0.19) | |
Consolidated Statements of Cash Flows | |||
Net cash used in operating activities ........................................................................ | $(31,757) | $(54,748) | |
Net cash used in investing activities ......................................................................... | $(465,659) | $(178,693) | |
Net cash provided by financing activities ................................................................. | $765,824 | $403,754 | |
As of December 31, 2025 | |||||
(In thousands, except share and per share data) | Actual | As Adjusted (1) | As Further Adjusted (2)(3) | ||
Consolidated Balance Sheets | |||||
ASSETS | |||||
Current assets: | |||||
Cash and cash equivalents ........................................................ | $461,836 | $481,209 | $2,149,906 | ||
Grant receivables ...................................................................... | 10,580 | 10,580 | 10,580 | ||
Prepaid expenses and other ...................................................... | 9,714 | 9,714 | 9,714 | ||
Total current assets .............................................................. | 482,130 | 501,503 | 2,170,200 | ||
Deposits .................................................................................... | 15,234 | 15,234 | 15,234 | ||
Construction-in-process ............................................................ | 789,571 | 789,571 | 789,571 | ||
Operating leases right of use assets .......................................... | 58,713 | 58,713 | 58,713 | ||
Restricted cash .......................................................................... | 6,000 | 6,000 | 6,000 | ||
Other long-term assets ............................................................... | 13,520 | 13,520 | 13,520 | ||
Total assets ........................................................................... | $1,365,168 | $1,384,541 | $3,053,238 | ||
LIABILITIES AND EQUITY | |||||
Current liabilities: | |||||
Accounts payable ......................................................................... | $10,789 | $10,789 | $10,789 | ||
Accrued capital expenditures ........................................................ | 119,303 | 119,303 | 119,303 | ||
Operating lease liabilities ............................................................ | 4,822 | 4,822 | 4,822 | ||
Other current liabilities ............................................................... | 16,997 | 16,997 | 16,997 | ||
Total current liabilities ........................................................... | 151,911 | 151,911 | 151,911 | ||
Long-term debt, net of issuance costs (4) .................................... | 172,837 | 182,452 | 182,452 | ||
Operating lease liabilities ......................................................... | 72,639 | 72,639 | 72,639 | ||
Other long-term liabilities ........................................................ | 11,407 | 1,193 | 1,193 | ||
Total liabilities ..................................................................... | 408,794 | 408,195 | 408,195 | ||
Commitments and Contingencies (Note 21) ............................. | |||||
Redeemable convertible preferred stock | |||||
Redeemable convertible preferred stock, par value $0.0001 per share; 283,545,547 authorized; 279,995,218 issued and outstanding on an actual basis, no shares issued and outstanding on an as adjusted basis, no shares issued and outstanding on an as further adjusted basis ........................... | 1,022,942 | — | — | ||
Redeemable noncontrolling interest | |||||
Cape Phase I HoldCo - Redeemable noncontrolling interest | 102,586 | 102,586 | 102,586 | ||
Cape Phase I Intermediate HoldCo - Redeemable noncontrolling interest ........................................................... | 77,344 | 77,344 | 77,344 | ||
Stockholders’ (deficit) equity: | |||||
Common stock, par value $0.0001 per share; 358,278,774 authorized; 13,145,979 issued and outstanding as of December 31, 2025 ................................................................ | 1 | — | — | ||
Class A common stock, par value $0.0001 per share; 1,000,000,000 shares authorized, no shares issued and outstanding on an actual basis, 205,776,919 shares issued and outstanding on an as adjusted basis, 275,776,919 shares issued and outstanding on an as further adjusted basis .......... | — | 21 | 28 | ||
As of December 31, 2025 | |||||
(In thousands, except share and per share data) | Actual | As Adjusted (1) | As Further Adjusted (2)(3) | ||
Class B common stock, par value $0.0001 per share: 40,000,000 shares authorized, no shares issued and outstanding on an actual basis, 7,785,414 shares issued and outstanding on an as adjusted basis, 7,785,414 shares issued and outstanding on an as further adjusted basis .......... | — | 1 | 1 | ||
Preferred stock, par value $0.0001 per share: no shares authorized on an actual basis and 10,000,000 shares authorized on an adjusted basis and no shares outstanding on an actual or as further adjusted basis ................................ | — | — | — | ||
Additional paid-in capital ......................................................... | — | 1,086,090 | 2,758,354 | ||
Treasury stock, at cost; 375,448 shares on an actual basis, and no shares on an as adjusted basis or an as further adjusted basis ....................................................................................... | (1,960) | — | — | ||
Accumulated deficit .................................................................. | (244,539) | (289,696) | (293,270) | ||
Total stockholders’ (deficit) equity ........................................ | (246,498) | 796,416 | 2,465,113 | ||
Total liabilities, redeemable convertible preferred stock, redeemable noncontrolling interests and stockholders’ (deficit) equity ................................................ | $1,365,168 | $1,384,541 | $3,053,238 | ||
As of December 31, 2025 | |||||
(In thousands, except share and per share data) | Actual | As Adjusted (1) | As Further Adjusted (2)(3) | ||
Cash and cash equivalents ............................................................. | $461,836 | $481,209 | $2,149,906 | ||
Indebtedness: | |||||
XRC Facility, Credit Facility and Project Granite Facility (1)(4) ... | 175,600 | 202,306 | 202,306 | ||
Redeemable convertible preferred stock, par value $0.0001 per share; 283,545,547 authorized; 279,995,218 issued and outstanding on an actual basis, no shares issued and outstanding on an as adjusted basis, no shares issued and outstanding on an as further adjusted basis ................................ | 1,022,942 | — | — | ||
Cape Phase I HoldCo - Redeemable noncontrolling interest ......... | 102,586 | 102,586 | 102,586 | ||
Cape Phase I Intermediate HoldCo - Redeemable noncontrolling interest ......................................................................................... | 77,344 | 77,344 | 77,344 | ||
Stockholders' (deficit) equity: | |||||
Common stock, par value $0.0001 per share; 358,278,774 authorized; 13,145,979 issued and outstanding as of December 31, 2025 ................................................................. | 1 | — | — | ||
Class A common stock, par value $0.0001 per share: 1,000,000,000 shares authorized, no shares issued and outstanding on an actual basis, 205,776,919 shares issued and outstanding on an as adjusted basis, 275,776,919 shares issued and outstanding on an as further adjusted basis ............ | — | 21 | 28 | ||
Class B common stock, par value $0.0001 per share: 40,000,000 shares authorized, no shares issued and outstanding on an actual basis, 7,785,414 shares issued and outstanding on an as adjusted basis, 7,785,414 shares issued and outstanding on an as further adjusted basis ....................... | — | 1 | 1 | ||
As of December 31, 2025 | |||||
(In thousands, except share and per share data) | Actual | As Adjusted (1) | As Further Adjusted (2)(3) | ||
Preferred stock, par value $0.0001 par value per share: no shares authorized on an actual basis and 10,000,000 shares authorized on an adjusted basis and no shares outstanding on an actual or as further adjusted ................................................. | — | — | — | ||
Additional paid-in capital ............................................................ | — | 1,086,090 | 2,758,354 | ||
Treasury stock, at cost; 375,448 shares on an actual basis, and no shares on an as adjusted basis or an as further adjusted basis .......................................................................................... | (1,960) | — | — | ||
Accumulated deficit ..................................................................... | (244,539) | (289,696) | (293,270) | ||
Total stockholders' (deficit) equity ........................................... | (246,498) | 796,416 | 2,465,113 | ||
Total capitalization ......................................................................... | $1,131,974 | $1,178,652 | $2,847,349 | ||
Assumed initial public offering price per share of Class A common stock ........... | $25.50 | ||
Historical net tangible book value (deficit) per share as of December 31, 2025 ... | $4.20 | ||
Increase per share attributable to the adjustments described above ....................... | 0.10 | ||
As adjusted net tangible book value per share as of December 31, 2025 .............. | 4.30 | ||
Increase in adjusted net tangible book value per share attributable to investors purchasing shares of Class A common stock in this offering ............................ | 4.82 | ||
As further adjusted net tangible book value per share immediately after this offering ............................................................................................................... | $9.12 | ||
Dilution in adjusted net tangible book value per share to investors in this offering ............................................................................................................... | $16.38 |
Shares Purchased | Total Consideration | Average price per Share | |||||||
Number | Percent | Amount | Percent | ||||||
Existing stockholders before this offering ........................................... | 213,562,333 | 75.31% | $1,028,851,360 | 36.56% | $4.82 | ||||
Investors participating in this offering | 70,000,000 | 24.69% | $1,785,000,000 | 63.44% | $25.50 | ||||
Total .................................................. | 283,562,333 | 100.00% | $2,813,851,360 | 100.00% | $9.92 | ||||
Year Ended December 31, | Change | ||||||
(Dollars in thousands, except percentages) | 2025 | 2024 | $ | % | |||
Revenues ............................................................ | $138 | $199 | $(61) | (31)% | |||
Costs and expenses: | |||||||
Operation and maintenance ............................. | 388 | 380 | 7 | 2% | |||
Research and development income, net ............ | (133) | (97) | (36) | 37% | |||
General and administrative expenses ............... | 38,718 | 34,735 | 3,983 | 11% | |||
Operating lease expenses ................................. | 9,681 | 6,895 | 2,786 | 40% | |||
Depreciation and amortization .......................... | 290 | 124 | 167 | 135% | |||
Operating loss ................................................ | (48,806) | (41,838) | (6,969) | 17% | |||
Other income (expense): | |||||||
Interest income ................................................ | 4,192 | 1,787 | 2,405 | 135% | |||
Interest expense ............................................... | (8,406) | (766) | (7,640) | 997% | |||
Other non-operating expense ............................ | (4,767) | (237) | (4,529) | 1909% | |||
Loss before income taxes ............................... | (57,787) | (41,054) | (16,733) | 41% | |||
Income tax expense .......................................... | (1) | (56) | 55 | (99)% | |||
Net loss ............................................................... | $(57,788) | $(41,110) | $(16,678) | 41% | |||
Year Ended December 31, | |||
(Dollars in thousands) | 2025 | 2024 | |
Beginning cash, cash equivalents and restricted cash ............................................... | $199,428 | $29,115 | |
Net cash (used in) provided by: | |||
Operating activities ................................................................................................. | (31,757) | (54,748) | |
Investing activities ................................................................................................... | (465,659) | (178,693) | |
Financing activities ................................................................................................. | 765,824 | 403,754 | |
Net increase in cash, cash equivalents and restricted cash ........................................ | 268,408 | 170,313 | |
Ending cash, cash equivalents and restricted cash ..................................................... | $467,836 | $199,428 | |








Country | Ownership | Patent Number | Type of Patent | Relevant Technology | ||||
United States | Fervo Energy Company | 11927369 | Utility | A method and system that may be used for storing energy in a geothermal system and recovering both the stored energy as well as thermal energy on demand. | ||||
United States | Fervo Energy Company | 11808121 | Utility | Encourage even distribution of fluid flow across multiple fracture zones intersecting a horizontal well by using the Limited Entry Perforation Pressure Drop effect both during stimulation and long- term circulation. | ||||
United States | Fervo Energy Company | 12281550 | Utility | Encourage even distribution of fluid flow across multiple fracture zones intersecting a horizontal well by using the Limited Entry Perforation Pressure Drop effect both during stimulation and long- term circulation. | ||||
United States | Fervo Energy Company | 12297724 | Utility | Manipulate near-wellbore properties of the wellbore or the formation using chemical or mechanical processes to improve and control fluid flow distribution along a horizontal well. | ||||
United States | Fervo Energy Company | 12378866 | Utility | A method and system that may be used for storing energy in a geothermal system and recovering both the stored energy as well as thermal energy on demand. | ||||
United States | Fervo Energy Company | 12535246 | Utility | A method and system that may be used for storing energy in a geothermal system and recovering both the stored energy as well as thermal energy on demand. |
Name | Age | Position(s) | ||
Executive Officers | ||||
Tim Latimer ................................ | 36 | Chief Executive Officer and Chair of the Board | ||
Jack Norbeck ............................... | 38 | Chief Technology Officer | ||
David Ulrey ................................. | 39 | Chief Financial Officer | ||
Gustavo Torres ............................ | 45 | Senior Vice President, General Counsel & Corporate Secretary | ||
Sarah Jewett ................................ | 36 | Senior Vice President, Strategy | ||
Quinn Woodard Jr. ...................... | 37 | Vice President, Operations | ||
Dawn Owens ............................... | 42 | Senior Vice President, Head of Development & Commercial Markets | ||
Christian Gradl ............................ | 43 | Senior Vice President, GeoBlock Factory | ||
Directors | ||||
Tim Latimer ................................ | 36 | Chief Executive Officer and Chair of the Board | ||
Margaret C. Whitman*(³) ............ | 69 | Lead Independent Director | ||
Robert Keehan(²)(³) ....................... | 60 | Director and Chair of the Audit Committee | ||
Jessica Uhl(¹)(²) ............................. | 58 | Director and Chair of the Nominating and Corporate Governance Committee | ||
Anne Cleary(²)(³) .......................... | 65 | Director and Chair of the Compensation Committee | ||
Robert (Trey) Lowe III(¹) ............ | 50 | Director | ||
Ion Yadigaroglu(¹) ....................... | 56 | Director |
Name and Principal Position | Year | Salary ($)(1) | Option Awards ($)(2) | Non-Equity Incentive Plan Compensation ($) | All Other Compensation ($)(3) | Total ($) | ||||||
Timothy Latimer Chief Executive Officer ................ | 2025 | 349,846 | 9,667,045 | 150,405 | 799,853 | 10,967,149 | ||||||
Jack Norbeck, Ph.D. Chief Technology Officer ............. | 2025 | 312,287 | 1,453,726 | 101,876 | 432,253 | 2,300,142 | ||||||
David Ulrey Chief Financial Officer ................ | 2025 | 337,077 | 2,180,589 | 113,280 | 53,499 | 2,684,445 |
Named Executive Officer | Number of Shares Subject to Options Granted in 2025 | |
Timothy Latimer .................................................................................................................................. | 2,391,947 | |
Jack Norbeck, Ph.D. ............................................................................................................................ | 359,700 | |
David Ulrey ......................................................................................................................................... | 539,550 |
Market Capitalization Milestone Condition* | Number of Shares | |
Prior to the fifth anniversary of the grant date, a market capitalization equal to or exceeding $20 billion at a time when we are the largest geothermal operator in the world, measured by installed capacity. ............................................................................................................................. | 2,431,497 | |
A market capitalization equal to or exceeding $40 billion at a time when we have installed at least five gigawatts of capacity. ................................................................................................................ | 2,431,497 | |
A market capitalization equal to or exceeding $80 billion at a time when we have installed at least ten gigawatts of capacity. ................................................................................................................. | 2,431,497 |
Name | Grant Date | Vesting Commencement Date | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price ($) | Option Expiration Date | ||||||||
Timothy Latimer ............... | July 14, 2023 | (1) | January 1, 2023 | 1,258,950 | 143,880 | 1.31 | July 13, 2033 | |||||||
December 29, 2025 | (2) | December 29, 2025 | — | 2,391,947 | 5.91 | December 28, 2035 | ||||||||
Jack Norbeck, Ph.D. ......... | July 14, 2023 | (1) | January 1, 2023 | 629,475 | 71,940 | 1.31 | July 13, 2033 | |||||||
December 29, 2025 | (2) | December 29, 2025 | — | 359,700 | 5.91 | December 28, 2035 | ||||||||
David Ulrey ...................... | June 28, 2021 | June 16, 2021 | 359,700 | — | 0.40 | June 27, 2031 | ||||||||
November 29, 2022 | (2) | November 29, 2022 | 249,541 | 74,188 | 1.31 | November 28, 2032 | ||||||||
May 13, 2024 | (2) | May 1, 2024 | 142,380 | 217,319 | 1.37 | May 12, 2034 | ||||||||
December 29, 2025 | (3) | December 29, 2025 | — | 539,550 | 5.91 | December 28, 2035 | ||||||||
Name | Option Awards ($)(1) | Total ($) | ||
Anne Cleary .............................................................................................................. | — | — | ||
Tanuj Dutta(²) ........................................................................................................... | — | — | ||
Christina Karapataki(²) ............................................................................................. | — | — | ||
Rachel Slaybaugh(²) ................................................................................................. | — | — | ||
Jane Woodward(²) .................................................................................................... | 47,520 | 47,520 | ||
Ion Yadigaroglu ....................................................................................................... | — | — |
Name | Options Outstanding at Fiscal Year End | |
Anne Cleary ......................................................................................................................................... | 143,880 | |
Tanuj Dutta .......................................................................................................................................... | — | |
Christina Karapataki ............................................................................................................................ | — | |
Rachel Slaybaugh ................................................................................................................................ | — | |
Jane Woodward ................................................................................................................................... | 13,848 | |
Ion Yadigaroglu ................................................................................................................................... | — |
Class A common stock | Class B common stock | Before Offering | After Giving Effect to the Offering | |||||||||||||||||
Before Offering | After Offering | Before Offering | After Offering | |||||||||||||||||
5% Holders | Shares | Percent | Shares | Percent | Shares | Percent | Shares | Percent | Percentage of total voting power (1) | |||||||||||
Devon Energy Corporation(2) . | 35,728,296 | 17.4% | 35,728,296 | 13.0% | — | — | — | — | 6.9% | 6.1% | ||||||||||
Capricorn Investment Group(3) .......... | 34,227,390 | 16.6% | 34,227,390 | 12.4% | — | — | — | — | 6.6% | 5.8% | ||||||||||
DCVC(4) .............. | 18,114,022 | 8.8% | 18,114,022 | 6.6% | — | — | — | — | 3.5% | 3.1% | ||||||||||
Breakthrough Energy Ventures(5) ...... | 14,074,589 | 6.8% | 14,074,589 | 5.1% | — | — | — | — | 2.7% | 2.4% | ||||||||||
Centaurus Capital LP(6) ... | 12,793,504 | 6.2% | 12,793,504 | 4.6% | — | — | — | — | 2.5% | 2.2% | ||||||||||
NEOs & Directors ......... | ||||||||||||||||||||
Anne Cleary(7) .... | 161,865 | * | 161,865 | * | — | — | — | — | * | * | ||||||||||
Sarah Jewett(8) .... | 673,687 | * | 673,687 | * | — | — | — | — | * | * | ||||||||||
Robert Keehan .... | — | — | — | — | — | — | — | — | — | — | ||||||||||
Tim Latimer(9) .... | — | — | — | — | 7,700,753 | 79.1% | 7,700,753 | 83.8% | 53.7% | 47.9% | ||||||||||
Trey Lowe .......... | — | — | — | — | — | — | — | — | — | — | ||||||||||
Jack Norbeck(10) .. | — | — | — | — | 2,188,905 | 25.0% | 2,188,905 | 25.8% | 16.1% | 14.2% | ||||||||||
Dawn Owens(11) .. | 716,102 | * | 716,102 | * | — | — | — | — | * | * | ||||||||||
Gustavo Torres(12) ......... | 229,307 | * | 229,307 | * | — | — | — | * | * | |||||||||||
Jessica Uhl .......... | — | — | — | - | — | — | — | — | — | — | ||||||||||
David Ulrey(13) .... | 837,051 | * | 837,051 | * | — | — | — | — | * | * | ||||||||||
Margaret Whitman ......... | — | — | — | — | — | — | — | — | - | - | ||||||||||
Quinn Woodard Jr.(14) ............... | 226,310 | * | 226,310 | * | — | — | — | — | * | * | ||||||||||
Ion Yadigaroglu(3) | 34,227,390 | 16.6% | 34,227,390 | 12.4% | — | — | — | — | 6.6% | 5.8% | ||||||||||
All executive officers, directors and director nominees as a group (14) individuals ...... | 37,807,960 | 17.9% | 37,807,960 | 13.4% | 9,889,658 | 100% | 9,889,658 | 100% | 71.8% | 64.3% | ||||||||||
Subscriber | Issuance Date | Shares Issued (Series) | Subscription Price (per share) | |||
Congruent Continuity Fund I, LP ........................ | Feb 2024 | 2,961,734 (Series D-1) | $2.53230 | |||
Congruent Cosine Fund I, LP .............................. | Feb 2024 | 987,244 (Series D-1) | $2.53230 | |||
DCVC Climate Select L.P. .................................. | Feb 2024 | 3,948,979 (Series D-1) | $2.53230 | |||
DCVC VI, L.P. ..................................................... | Feb 2024 | 3,948,978 (Series D-1) | $2.53230 | |||
Technology Impact Growth Fund II, L.P. ............ | Feb 2024 | 3,948,977 (Series D-1) | $2.53230 | |||
Energy Climate Capital I, LLC ............................ | Feb 2024 | 786,217 (Series D-1) | $2.53230 | |||
DCVC Climate Select L.P. .................................. | Dec 2024 | 946,754 (Series D-3) | $5.28120 | |||
DCVC VI, L.P. ..................................................... | Dec 2024 | 946,754 (Series D-3) | $5.28120 | |||
TIGF II Direct Strategies LLC – Series 5 ............ | Dec 2024 | 7,574,036 (Series D-3) | $5.28120 | |||
Technology Impact Growth Fund II, L.P. ............ | Dec 2024 | 3,787,018 (Series D-3) | $5.28120 | |||
Breakthrough Energy Ventures Select Fund I, L.P. ................................................................... | Dec 2024 | 1,420,131 (Series D-3) | $5.28120 | |||
Congruent Continuity Fund I, LP ........................ | Dec 2024 | 946,754 (Series D-3) | $5.28120 | |||
Congruent Cosine Fund I, LP .............................. | Dec 2024 | 378,701 (Series D-3) | $5.28120 | |||
Devon Technology Ventures Holdings, L.L.C. ... | Dec 2025 | 6,118,752 (Series E-1) | $8.17160 | |||
Breakthrough Energy Ventures Select Fund I, L.P. .................................................................. | Dec 2025 | 2,141,563 (Series E-1) | $8.17160 | |||
Congruent Continuity Fund I, LP ........................ | Dec 2025 | 611,875 (Series E-1) | $8.17160 | |||
Congruent Cosine Fund I, LP .............................. | Dec 2025 | 1,223,750 (Series E-1) | $8.17160 | |||
DCVC Climate Select, L.P. ................................. | Dec 2025 | 1,223,750 (Series E-1) | $8.17160 | |||
DCVC VI, L.P. ..................................................... | Dec 2025 | 1,921,288 (Series E-1) | $8.17160 | |||
Technology Impact Growth Fund II, L.P. ............ | Dec 2025 | 1,223,750 (Series E-1) | $8.17160 | |||
TIGF II Direct Strategies LLC - Series 7 ............. | Dec 2025 | 2,447,501 (Series E-1) | $8.17160 |
Name | Number of Shares | |
J.P. Morgan Securities LLC ................................................................................................................. | ||
BofA Securities, Inc. ............................................................................................................................ | ||
RBC Capital Markets, LLC ................................................................................................................. | ||
Barclays Capital Inc. ............................................................................................................................. | ||
Robert W. Baird & Co. Incorporated .................................................................................................... | ||
BBVA Securities Inc. ............................................................................................................................ | ||
Guggenheim Securities, LLC ................................................................................................................ | ||
MUFG Securities Americas Inc. ........................................................................................................... | ||
SG Americas Securities, LLC ............................................................................................................... | ||
William Blair & Company, L.L.C. ....................................................................................................... | ||
Piper Sandler & Co. ............................................................................................................................. | ||
Nomura Securities International, Inc. ................................................................................................... | ||
WR Securities, LLC .............................................................................................................................. | ||
Total ...................................................................................................................................................... | 70,000,000 |
Without option to purchase additional shares exercise | With full option to purchase additional shares exercise | ||
Per Share .................................................................................................................... | $ | $ | |
Total ........................................................................................................................... | $ | $ |
Page | |
Report of Independent Registered Public Accounting Firm ............................................................................. | |
Consolidated Balance Sheets ....................................................................................................................... | |
Consolidated Statements of Operations ....................................................................................................... | |
Stockholders’ Deficit ................................................................................................................................ | |
Consolidated Statements of Cash Flows ...................................................................................................... | |
Notes to Consolidated Financial Statements ................................................................................................ |
(Dollars and shares in thousands) | As of December 31, | ||
2025 | 2024 | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents ................................................................................... | $461,836 | $193,428 | |
Grant receivables ................................................................................................. | 10,580 | 3,952 | |
Prepaid expenses and other .................................................................................. | 9,714 | 7,917 | |
Total current assets .......................................................................................... | 482,130 | 205,297 | |
Deposits ............................................................................................................... | 15,234 | 25,020 | |
Construction-in-process ....................................................................................... | 789,571 | 258,900 | |
Operating leases right of use assets ..................................................................... | 58,713 | 25,672 | |
Restricted cash ..................................................................................................... | 6,000 | 6,000 | |
Other long-term assets .......................................................................................... | 13,520 | 10,410 | |
Total assets ...................................................................................................... | $1,365,168 | $531,299 | |
LIABILITIES AND EQUITY | |||
Current liabilities: | |||
Accounts payable .................................................................................................... | $10,789 | $35,036 | |
Accrued capital expenditures .................................................................................. | 119,303 | 22,869 | |
Operating lease liabilities ....................................................................................... | 4,822 | 1,928 | |
Other current liabilities ........................................................................................... | 16,997 | 6,992 | |
Total current liabilities ...................................................................................... | 151,911 | 66,825 | |
Long-term debt, net of issuance costs .................................................................... | 172,837 | 39,019 | |
Operating lease liabilities ....................................................................................... | 72,639 | 40,851 | |
Other long-term liabilities ...................................................................................... | 11,407 | 299 | |
Total liabilities ................................................................................................ | 408,794 | 146,994 | |
Commitments and Contingencies (Note 21) ........................................................... | |||
Redeemable convertible preferred stock | |||
Redeemable convertible preferred stock, par value $0.0001 per share; 283,546 and 223,458 authorized; 279,995 and 223,458 issued and outstanding as of December 31, 2025 and 2024, respectively ........................................................ | 1,022,942 | 561,500 | |
Redeemable noncontrolling interest | |||
Cape Phase I HoldCo - Redeemable noncontrolling interest ................................ | 102,586 | — | |
Cape Phase I Intermediate HoldCo - Redeemable noncontrolling interest .......... | 77,344 | — | |
Stockholders’ (deficit) equity: | |||
Common stock, par value $0.0001 per share; 358,279 and 280,000 authorized; 13,146 and 12,470 issued and outstanding as of December 31, 2025 and 2024, respectively ............................................................................................ | 1 | 1 | |
Additional paid-in capital .................................................................................... | — | 2,582 | |
Treasury stock, at cost; 375 and 0 shares as of December 31, 2025 and 2024, respectively ...................................................................................................... | (1,960) | — | |
Accumulated deficit ............................................................................................. | (244,539) | (179,778) | |
Total stockholders’ (deficit) equity ................................................................... | (246,498) | (177,195) | |
Total liabilities, redeemable convertible preferred stock, redeemable noncontrolling interests and stockholders’ (deficit) equity ......................... | $1,365,168 | $531,299 | |
(Dollars in thousands) | As of December 31, |
2025 | |
Assets of consolidated VIEs, included in total assets above: | |
Cash and cash equivalents ................................................................................................................ | $13,882 |
Prepaid expenses and other .............................................................................................................. | 545 |
Total current assets ........................................................................................................................ | 14,427 |
Deposits ............................................................................................................................................ | 7,158 |
Construction-in-process ................................................................................................................... | 361,213 |
Total assets of consolidated VIEs ............................................................................................... | 382,798 |
Liabilities of consolidated VIEs, included in total liabilities above: | |
Accrued capital expenditures.............................................................................................................. | 17,061 |
Other current liabilities ....................................................................................................................... | 2,970 |
Total current liabilities ..................................................................................................................... | 20,031 |
Long-term debt, net of issuance costs ................................................................................................ | 142,837 |
Other long-term liabilities .................................................................................................................. | 1,468 |
Total liabilities of consolidated VIEs .......................................................................................... | 164,336 |
Total net assets of consolidated VIEs ............................................................................................... | $218,462 |
(Dollars and shares in thousands except per share amounts) | Year ended December 31, | ||
2025 | 2024 | ||
Revenues ................................................................................................................... | $138 | $199 | |
Costs and expenses: | |||
Operation and maintenance .................................................................................... | 388 | 380 | |
Research and development income, net .................................................................. | (133) | (97) | |
General and administrative expenses ..................................................................... | 38,718 | 34,735 | |
Operating lease expenses ....................................................................................... | 9,681 | 6,895 | |
Depreciation and amortization ................................................................................ | 290 | 124 | |
Operating loss ...................................................................................................... | (48,806) | (41,838) | |
Other income (expense): | |||
Interest income ....................................................................................................... | 4,192 | 1,787 | |
Interest expense ...................................................................................................... | (8,406) | (766) | |
Other non-operating expense .................................................................................. | (4,767) | (237) | |
Loss before income taxes .......................................................................................... | (57,787) | (41,054) | |
Income tax expense ................................................................................................. | (1) | (56) | |
Net loss ..................................................................................................................... | $(57,788) | $(41,110) | |
Net loss per share information: | |||
Net loss ................................................................................................................... | $(57,788) | $(41,110) | |
Less: Remeasurement of redeemable noncontrolling interest ................................. | (12,727) | — | |
Net loss attributable to common shares, basic and diluted .................................... | (70,515) | (41,110) | |
Weighted average shares, basic and diluted ...................................................... | 12,462 | 12,438 | |
Net loss per share attributable to common stockholders, basic and diluted ...... | $(5.66) | $(3.31) | |
Redeemable convertible preferred stock | Redeemable non- controlling interest | Common stock | Treasury stock | Additional paid-in capital | Accumulated deficit | Total stockholders’ deficit | ||||||||||||||||
(Dollars and shares in thousands) | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||
Balance at January 1, 2025 ........ | 223,458 | $561,500 | — | $— | 12,470 | $1 | — | $— | $2,582 | $(179,778) | $(177,195) | |||||||||||
Issuance of shares in subsidiaries, net of issuance cost of $973 ........................... | — | — | 12 | 167,203 | — | — | — | — | — | — | — | |||||||||||
Remeasurement of redeemable noncontrolling interests ......... | — | — | — | 12,727 | — | — | — | — | (5,754) | (6,973) | (12,727) | |||||||||||
Issuance of Series E-1 redeemable convertible preferred stock, net of issuance cost of $558 ............. | 56,537 | 461,442 | — | — | — | — | — | — | — | — | — | |||||||||||
Repurchase of shares ................. | — | — | — | — | — | — | 375 | (1,960) | — | — | (1,960) | |||||||||||
Stock-based compensation ........ | — | — | — | — | — | — | — | — | 2,665 | — | 2,665 | |||||||||||
Exercise of stock-based awards by employees and directors ... | — | — | — | — | 676 | — | — | — | 507 | — | 507 | |||||||||||
Net loss ...................................... | — | — | — | — | — | — | — | — | — | (57,788) | (57,788) | |||||||||||
Balance at December 31, 2025 .. | 279,995 | $1,022,942 | 12 | $179,930 | 13,146 | $1 | 375 | $(1,960) | $— | $(244,539) | $(246,498) | |||||||||||
Redeemable convertible preferred stock | Common stock | Additional paid- in capital | Accumulated deficit | Total stockholders’ deficit | ||||||||||
(Dollars and shares in thousands) | Shares | Amount | Shares | Amount | ||||||||||
Balance at January 1, 2024 .................... | 100,768 | $182,257 | 12,341 | $1 | $1,142 | $(138,668) | $(137,525) | |||||||
Issuance of Series D-1 redeemable convertible preferred stock, net of issuance costs of $1,090 ...................... | 92,344 | 232,753 | — | — | — | — | — | |||||||
Conversion of 2023 convertible notes to Series D-2 redeemable convertible preferred stock ..................................... | 4,766 | 12,025 | — | — | — | — | — | |||||||
Issuance of Series D-3 redeemable convertible preferred stock, net of issuance costs of $627 .......................... | 25,468 | 133,873 | — | — | — | — | — | |||||||
Conversion of Simple Agreement for Future Equity (“SAFE”) to Series D-4 redeemable convertible preferred stock ..................................................... | 112 | 592 | — | — | — | — | — | |||||||
Stock-based compensation ..................... | — | — | — | — | 1,370 | — | 1,370 | |||||||
Exercise of stock-based awards by employees and directors ...................... | — | — | 129 | — | 70 | — | 70 | |||||||
Net loss .................................................... | — | — | — | — | — | (41,110) | (41,110) | |||||||
Balance at December 31, 2024 .............. | 223,458 | $561,500 | 12,470 | $1 | $2,582 | $(179,778) | $(177,195) | |||||||
(Dollars in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
Cash flows from operating activities: | |||
Net loss ..................................................................................................................... | $(57,788) | $(41,110) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||
Depreciation and amortization ............................................................................. | 290 | 124 | |
Amortization of debt issuance costs ..................................................................... | 1,946 | 689 | |
Stock-based compensation ................................................................................... | 2,665 | 1,370 | |
Non-cash expense related to long-term operating leases ..................................... | 3,973 | 4,091 | |
Non-cash expense related to warrant valuation .................................................... | 3,390 | — | |
Non-cash expense related to derivative valuation ................................................ | 1,680 | — | |
Changes in operating assets and liabilities: | |||
Grant receivables .............................................................................................. | — | (1,764) | |
Prepaid expenses and other .............................................................................. | (1,797) | (7,043) | |
Other ............................................................................................................... | — | (7,430) | |
Deposits ........................................................................................................... | 9,785 | (7,106) | |
Accounts payable ............................................................................................. | (2,857) | 3,503 | |
Other current liabilities ................................................................................... | 6,956 | (72) | |
Net cash used in operating activities .......................................................... | (31,757) | (54,748) | |
Cash flows from investing activities: | |||
Capital expenditures ................................................................................................. | (465,659) | (178,693) | |
Net cash used in investing activities .................................................................... | (465,659) | (178,693) | |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock ................................................................ | 492 | 70 | |
Proceeds from issuance of redeemable convertible preferred stock .......................... | 462,000 | 368,343 | |
Issuance costs related to redeemable convertible preferred stock ............................. | (558) | (1,717) | |
Proceeds from issuance of subsidiary stock .............................................................. | 168,176 | — | |
Issuance costs related to subsidiary stock .................................................................. | (973) | — | |
Proceeds from issuance of warrants .......................................................................... | 6,824 | — | |
Proceeds from issuance of SAFE .............................................................................. | — | 500 | |
Proceeds from long-term debt .................................................................................. | 134,961 | 40,684 | |
Debt issuance costs related to long-term debt .......................................................... | (3,155) | (4,126) | |
Treasury stock purchased .......................................................................................... | (1,943) | — | |
Net cash provided by financing activities ............................................................ | 765,824 | 403,754 | |
Net change in cash and cash equivalents and restricted cash ................................... | 268,408 | 170,313 | |
Cash and cash equivalents and restricted cash at beginning of period ..................... | 199,428 | 29,115 | |
Cash and cash equivalents and restricted cash at end of period ............................... | $467,836 | $199,428 | |
Supplemental disclosure of cash flow information: | |||
Accrued capital expenditures (at end of period) ....................................................... | 129,051 | 54,146 | |
Adjustment of redeemable noncontrolling interest .................................................... | 12,727 | — | |
Cash paid for interest, net of amounts capitalized ..................................................... | 8,266 | — | |
Cash paid for taxes .................................................................................................... | 52 | 2 | |
Non-cash activity related to conversion of convertible note .................................... | — | 12,025 | |
Non-cash activity related to conversion of SAFE ..................................................... | — | 592 | |
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Cash ................................................................................................................... | $19,844 | $7,511 | |
Money market .................................................................................................... | 441,992 | 185,917 | |
Restricted cash ................................................................................................... | 6,000 | 6,000 | |
Total cash and cash equivalents and restricted cash .......................................... | $467,836 | $199,428 | |
Useful lives | |
Leasehold improvements ...................................................................................................................... | 5 years |
Equipment ............................................................................................................................................. | 15 years |
Office equipment .................................................................................................................................. | 5 years |
Office furniture ..................................................................................................................................... | 7 years |
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Long-term debt | |||
XRC Term Loan ............................................................................................ | $145,600 | $40,639 | |
Mercuria ........................................................................................................ | 30,000 | — | |
Total principal due for long-term debt ........................................................ | 175,600 | 40,639 | |
Less: Unamortized debt issuance cost .......................................................... | (2,763) | (1,620) | |
Total long-term debt, net of issuance costs .................................................... | $172,837 | $39,019 | |
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Beginning balance ............................................................................................. | $299 | $— | |
Liabilities incurred during the period ............................................................... | 843 | 299 | |
Accretion expense ............................................................................................. | 51 | — | |
Ending balance .................................................................................................. | $1,193 | $299 | |
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Accrued expenses .............................................................................................. | $9,035 | $2,848 | |
Bonus accrual ..................................................................................................... | 4,830 | 2,591 | |
Derivative ........................................................................................................... | 1,680 | — | |
Deferred grant income ....................................................................................... | 888 | 1,479 | |
Payroll liabilities ................................................................................................ | 564 | 74 | |
Total other current liabilities ............................................................................. | $16,997 | $6,992 | |
(Dollars in thousands) | As of December 31, | ||
Carrying values by asset category | 2025 | 2024 | |
ROU Asset: | |||
Geothermal land leases ................................................................................. | $45,609 | $24,316 | |
Office space ................................................................................................... | 6,635 | 952 | |
Equipment ..................................................................................................... | 6,188 | — | |
Vehicles ......................................................................................................... | 282 | 404 | |
Total ............................................................................................................ | $58,713 | $25,672 | |
Lease Liability(1): | |||
Geothermal land leases ................................................................................. | $62,744 | $41,420 | |
Office space ................................................................................................... | 8,144 | 969 | |
Equipment ..................................................................................................... | 6,300 | — | |
Vehicles ......................................................................................................... | 273 | 390 | |
Total ............................................................................................................ | $77,461 | $42,779 | |
By asset category | As of December 31, | ||
2025 | 2024 | ||
Weighted average remaining term | |||
Geothermal land leases ................................................................................. | 14 years | 16 years | |
Office space ................................................................................................... | 3 years | 1 year | |
Equipment ..................................................................................................... | 9 years | — | |
Vehicles ......................................................................................................... | 2 years | 3 years | |
Weighted average discount rate(2): | |||
Geothermal land leases ................................................................................. | 11% | 12% | |
Office space ................................................................................................... | 9% | 11% | |
Equipment ..................................................................................................... | 12% | —% | |
Vehicles ......................................................................................................... | 10% | 10% | |
(Dollars in thousands) | As of December 31, |
2025 | |
2026 ................................................................................................................................................... | $6,261 |
2027 ................................................................................................................................................... | 7,235 |
2028 ................................................................................................................................................... | 6,188 |
2029 ................................................................................................................................................... | 12,035 |
2030 ................................................................................................................................................... | 11,380 |
Thereafter .......................................................................................................................................... | 133,508 |
Total minimum lease payments ............................................................................................... | $176,607 |
Less: Amount representing interest .................................................................................................. | 99,146 |
Total lease obligation .............................................................................................................. | $77,461 |
Less: Current lease obligation .......................................................................................................... | 4,822 |
Long-term lease obligation ...................................................................................................... | $72,639 |
(Dollars in thousands, except per share amounts) | Shares Authorized | Shares Issued and Outstanding | Issuance Price Per Share | Carrying Value | Aggregate Liquidation Preference | ||||
As of December 31, 2025 | |||||||||
Series A .......................................... | 14,542 | 14,542 | 0.77 | $11,250 | $11,250 | ||||
Series A-1 ....................................... | 2,453 | 2,453 | 0.05 | 1,897 | 1,897 | ||||
Series B .......................................... | 24,597 | 24,596 | 1.15 | 28,324 | 28,324 | ||||
Series C-1 ....................................... | 43,482 | 43,482 | 2.53 | 110,100 | 110,100 | ||||
Series C-2 ....................................... | 5,018 | 5,018 | 2.03 | 12,665 | 12,665 | ||||
Series C-3 ....................................... | 10,676 | 10,676 | 1.69 | 18,021 | 18,021 | ||||
Series D-1 ....................................... | 92,344 | 92,344 | 2.53 | 232,753 | 233,843 | ||||
Series D-2 ....................................... | 4,767 | 4,767 | 2.15 | 12,025 | 12,025 | ||||
Series D-3 ....................................... | 25,468 | 25,468 | 5.28 | 133,873 | 134,500 | ||||
Series D-4 ....................................... | 112 | 112 | 4.49 | 592 | 592 | ||||
Series E-1 ....................................... | 56,537 | 56,537 | 8.17 | 461,442 | 462,000 | ||||
Series E-2 ....................................... | 3,550 | — | 5.28 | — | — | ||||
Total ........................................... | 283,546 | 279,995 | $1,022,942 | $1,025,217 |
(Dollars in thousands, except per share amounts) | Shares Authorized | Shares Issued and Outstanding | Issuance Price Per Share | Carrying Value | Aggregate Liquidation Preference | ||||
As of December 31, 2024 | |||||||||
Series A ........................................... | 14,542 | 14,542 | $0.77 | $11,250 | $11,250 | ||||
Series A-1 ....................................... | 2,453 | 2,453 | 0.05 | 1,897 | 1,897 | ||||
Series B ........................................... | 24,596 | 24,596 | 1.15 | 28,324 | 28,324 | ||||
Series C-1 ........................................ | 43,482 | 43,482 | 2.53 | 110,100 | 110,100 | ||||
Series C-2 ........................................ | 5,018 | 5,018 | 2.03 | 12,665 | 12,665 | ||||
Series C-3 ........................................ | 10,676 | 10,676 | 1.69 | 18,021 | 18,021 | ||||
Series D-1 ....................................... | 92,344 | 92,344 | 2.53 | 232,753 | 233,843 | ||||
Series D-2 ....................................... | 4,767 | 4,767 | 2.15 | 12,025 | 12,025 | ||||
Series D-3 ....................................... | 25,468 | 25,468 | 5.28 | 133,873 | 134,500 |
(Dollars in thousands, except per share amounts) | Shares Authorized | Shares Issued and Outstanding | Issuance Price Per Share | Carrying Value | Aggregate Liquidation Preference | ||||
Series D-4 ....................................... | 112 | 112 | 4.49 | 592 | 592 | ||||
Total .......................................... | 223,458 | 223,458 | $561,500 | $563,217 |
(Stock options data and aggregate intrinsic value in thousands) | Stock Options Outstanding | Weighted – Average Exercise Price | Weighted – Average Grant Date Fair Value | Weighted – Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value | ||||
Outstanding at January 1, 2025 ........ | 16,666 | $0.84 | $0.42 | $— | |||||
Granted ............................................. | 10,704 | 3.08 | 1.44 | — | |||||
Exercised .......................................... | (676) | 0.76 | 0.39 | 760 | |||||
Forfeited ........................................... | (416) | 1.62 | 1.03 | — | |||||
Expired ............................................. | (161) | 0.59 | 0.30 | — | |||||
Outstanding at December 31, 2025 .. | 26,117 | $1.75 | $1.10 | 8.36 | $65,348 | ||||
Vested and exercisable at December 31, 2025 .......................... | 10,466 | $0.80 | $0.40 | 7.09 | $36,148 |
Year ended December 31, | |||
2025 | 2024 | ||
Fair value of common stock .................................................................................................... | $2.12 - $4.25 | $0.98 | |
Expected volatility ................................................................................................................... | 75.0% | 70.0% | |
Expected term (in years) ......................................................................................................... | 3.08 - 6.08 | 3.08 | |
Risk-free interest rate .............................................................................................................. | 3.75% - 4.25% | 4.6% | |
Expected dividend yield .......................................................................................................... | 0.0% | 0.0% | |
At issuance | |
October 6, 2025 | |
Series D-3 Redeemable Convertible Preferred Stock price .................................................................. | $5.28 |
Expected volatility ................................................................................................................................ | 75.0% |
Expected term (in years) ...................................................................................................................... | 3.00 |
Risk-free interest rate ............................................................................................................................ | 3.6% |
Expected dividend yield ........................................................................................................................ | 0.0% |
As of December 31, 2025 | |||
Going concern scenario | IPO scenario | ||
Series D-3 Redeemable Convertible Preferred Stock price ....................................... | $8.17 | $8.17 | |
Expected volatility ..................................................................................................... | 75.0% | 75.0% | |
Expected term (in years) ............................................................................................ | 3.00 | 0.50 | |
Risk-free interest rate ................................................................................................. | 3.6% | 3.6% | |
Expected dividend yield ............................................................................................ | 0.0% | 0.0% | |
(Dollars in thousands) | |
Balance at December 31, 2024 ............................................................................................................. | $— |
Redeemable noncontrolling interests .................................................................................................... | 99,500 |
Remeasurement of redeemable noncontrolling interest ........................................................................ | 3,086 |
Balance at December 31, 2025 ............................................................................................................. | $102,586 |
(Dollars in thousands) | |
Balance at December 31, 2024 ............................................................................................................. | $— |
Redeemable noncontrolling interests .................................................................................................... | 67,703 |
Remeasurement of redeemable noncontrolling interest ........................................................................ | 9,641 |
Balance at December 31, 2025 ............................................................................................................. | $77,344 |
(Dollars and shares in thousands, except per share amounts) | Year ended December 31, | ||
2025 | 2024 | ||
Numerator: | |||
Net loss attributable to common shares ..................................................................... | $(70,515) | $(41,110) | |
Denominator: | |||
Weighted-average common shares ........................................................................... | 12,462 | 12,438 | |
Net loss per share – basic and diluted ................................................................. | $(5.66) | $(3.31) | |
(Shares in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
Preferred shares ........................................................................................................ | 279,995 | 223,458 | |
Options based awards ............................................................................................... | 26,117 | 17,826 | |
Warrants ..................................................................................................................... | 3,550 | — | |
Total .......................................................................................................................... | 309,662 | 241,284 | |
(Dollars in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
United States .............................................................................................................. | $(57,787) | $(41,054) | |
(Dollars in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
Current: | |||
Federal ..................................................................................................................... | $— | $53 | |
State and local ......................................................................................................... | 1 | 3 | |
Foreign .................................................................................................................... | — | — | |
Total ...................................................................................................................... | $1 | $56 | |
Deferred: | |||
Federal ..................................................................................................................... | $— | $— | |
State and local ......................................................................................................... | — | — | |
Foreign .................................................................................................................... | — | — | |
Total ...................................................................................................................... | $— | $— | |
Total income tax expense .......................................................................................... | $1 | $56 | |
Year ended December 31, 2025 | Year ended December 31, 2024 | ||||||
(Dollars in thousands) | Tax | Percent | Tax | Percent | |||
Tax benefit at U.S. Federal statutory rate ................... | $(12,135) | 21.0% | $(8,614) | 21.0% | |||
Increase (decrease) in income taxes resulting from: .. | |||||||
Conversion of notes ............................................... | — | —% | 25 | —% | |||
Stock options ......................................................... | — | —% | 192 | (0.5)% | |||
State taxes .............................................................. | 1 | —% | 3 | —% | |||
Other ...................................................................... | 468 | (0.8)% | 18 | —% | |||
Change in valuation allowance .............................. | 11,667 | (20.2)% | 8,432 | (20.6)% | |||
Total tax expense ........................................................ | $1 | —% | $56 | (0.1)% | |||
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Deferred Tax Assets | |||
Section 174 costs .............................................................................................. | $7,932 | $9,836 | |
Start-up costs ..................................................................................................... | 12,305 | 13,659 | |
NOL carryforward ............................................................................................ | 17,995 | 8,641 | |
Lease liability .................................................................................................... | 16,267 | 8,984 | |
Compensation ................................................................................................... | 1,204 | 657 | |
Grant revenue ..................................................................................................... | 2,458 | 821 | |
Inventory ............................................................................................................ | 8,252 | — | |
Investment in partnerships ................................................................................. | 1,272 | — | |
Other ................................................................................................................. | 583 | 248 | |
Deferred tax assets ............................................................................................ | $68,268 | $42,846 | |
Deferred Tax Liabilities | |||
Intangible drilling costs (IDC) .......................................................................... | $(9,145) | $(2,337) | |
Right of use asset .............................................................................................. | (12,330) | (5,391) | |
Total deferred tax liabilities .............................................................................. | $(21,475) | $(7,728) | |
Net deferred tax assets ....................................................................................... | 46,793 | 35,118 | |
Valuation allowance ......................................................................................... | (46,793) | (35,118) | |
Net deferred tax assets ....................................................................................... | $— | $— | |
(Dollars in thousands) | 2025 | 2024 | |
Balance at beginning of year .................................................................................... | $35,118 | $26,686 | |
Additions .................................................................................................................. | 11,667 | 8,432 | |
Prior year adjustment ................................................................................................. | 8 | — | |
Balance at end of year .............................................................................................. | $46,793 | $35,118 |
Fair value of common stock ................................................................................................................... | $4.25 - $8.49 |
Expected volatility .................................................................................................................................. | 75.0% |
Expected term (in years) ........................................................................................................................ | 6.08 |
Risk-free interest rate .............................................................................................................................. | 3.75% - 3.83% |
Expected dividend yield ......................................................................................................................... | 0.0% |

J.P. Morgan | BofA Securities | RBC Capital Markets | Barclays |
Baird | BBVA | Guggenheim Securities | MUFG |
Societe Generale | William Blair | Piper Sandler | Wolfe | Nomura Alliance |
Amount to be paid | |
SEC registration fee .............................................................................................................................. | $289,044 |
FINRA filing fee ................................................................................................................................... | $225,500 |
Exchange listing fee .............................................................................................................................. | $150,000 |
Accounting fees and expenses .............................................................................................................. | $3,000,000 |
Legal fees and expenses ........................................................................................................................ | $3,750,000 |
Printing and engraving expenses .......................................................................................................... | $200,000 |
Transfer agent and registrar fees ........................................................................................................... | $15,000 |
Miscellaneous expenses ........................................................................................................................ | $1,573,724 |
Total ...................................................................................................................................................... | $9,203,268 |
(Dollars and shares in thousands) | As of December 31, | ||
2025 | 2024 | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents .................................................................................... | $447,933 | $185,761 | |
Other current assets ............................................................................................... | 12,611 | 2,026 | |
Total current assets ............................................................................................. | 460,544 | 187,787 | |
Investment in subsidiaries ....................................................................................... | 483,807 | 243,642 | |
Other assets ............................................................................................................. | 16,083 | 1,951 | |
Total assets ......................................................................................................... | $960,434 | 433,380 | |
LIABILITIES AND EQUITY | |||
Current liabilities: | |||
Accounts payable .................................................................................................. | $10,789 | $20,524 | |
Accrued capital expenditures ................................................................................ | 78,708 | 20,654 | |
Due to Cape Phase I Intermediate HoldCo, LLC ................................................. | 63,349 | — | |
Other current liabilities ......................................................................................... | 13,476 | 7,504 | |
Total current liabilities ....................................................................................... | 166,322 | 48,682 | |
Other long-term liabilities ....................................................................................... | 17,668 | 393 | |
Total liabilities .................................................................................................... | 183,990 | 49,075 | |
Redeemable convertible preferred stock | |||
Redeemable convertible preferred stock, par value $0.0001 per share; 283,546 and 223,458 authorized; 279,995 and 223,458 issued and outstanding as of December 31, 2025 and 2024, respectively ........................................................ | 1,022,942 | 561,500 | |
Stockholders’ deficit: | |||
Common stock, par value $0.0001 per share; 358,279 and 280,000 authorized; 12,771 and 12,470 issued and outstanding as of December 31, 2025 and 2024, respectively ............................................................................................... | 1 | 1 | |
Additional paid-in capital ..................................................................................... | — | 2,582 | |
Treasury stock, at cost; 375 and 0 shares as of December 31, 2025 and 2024, respectively ........................................................................................................ | (1,960) | — | |
Accumulated deficit .............................................................................................. | (244,539) | (179,778) | |
Total stockholders’ deficit .................................................................................. | (246,498) | (177,195) | |
Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit ............................................................................................................... | $960,434 | $433,380 | |
(Dollars in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
Costs and expenses: | |||
Research and development expenses, net ............................................................. | $(133) | $(97) | |
General and administrative expenses .................................................................... | 36,412 | 33,606 | |
Operating loss ..................................................................................................... | (36,279) | (33,509) | |
Other income (expense): | |||
Interest income ...................................................................................................... | 4,192 | 1,478 | |
Other non-operating expense ................................................................................ | (2,769) | (439) | |
Equity in loss of subsidiaries ................................................................................ | (22,932) | (8,640) | |
Net loss ............................................................................................................... | $(57,788) | $(41,110) | |
(Dollars and shares in thousands) | Redeemable Convertible Preferred Stock | Common Stock | Treasury Stock | Additional paid-in capital | Accumulated Deficit | Total Stockholders’ Deficit | ||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||
Balance at January 1, 2024 ............ | 100,768 | $182,257 | 12,341 | $1 | — | $— | $1,142 | $(138,668) | $(137,525) | |||||||||
Issuance of Series D-1 redeemable convertible preferred stock, net of issuance costs of $1,090 ............... | 92,344 | 232,753 | — | — | — | — | — | — | — | |||||||||
Conversion of 2023 convertible notes to Series D-2 redeemable convertible preferred stock ........... | 4,766 | 12,025 | — | — | — | — | — | — | — | |||||||||
Issuance of Series D-3 redeemable convertible preferred stock, net of issuance costs of $627 .................. | 25,468 | 133,873 | — | — | — | — | — | — | — | |||||||||
Issuance of Series D-4 redeemable convertible preferred stock ........... | 112 | 592 | — | — | — | — | — | — | — | |||||||||
Stock-based compensation ............... | — | — | — | — | — | — | 1,370 | — | 1,370 | |||||||||
Exercise of stock-based awards by employees and directors ............... | — | — | 129 | — | — | — | 70 | — | 70 | |||||||||
Net loss ............................................. | — | — | — | — | — | — | — | (41,110) | (41,110) | |||||||||
Balance at December 31, 2024 ....... | 223,458 | $561,500 | 12,470 | $1 | — | $— | $2,582 | $(179,778) | $(177,195) | |||||||||
Remeasurement of redeemable non controlling interests in subsidiaries ................................... | — | — | — | — | — | — | (5,754) | (6,973) | (12,727) | |||||||||
Issuance of Series E redeemable convertible preferred stock, net of issuance cost of $558 .................... | 56,537 | 461,442 | — | — | — | — | — | — | ||||||||||
Repurchase of Shares ....................... | — | — | — | — | 375 | (1,960) | — | — | (1,960) | |||||||||
Stock-based compensation ............... | — | — | — | — | — | — | 2,665 | — | 2,665 | |||||||||
Exercise of stock-based awards by employees and directors ............... | — | — | 676 | — | — | — | 507 | — | 507 | |||||||||
Net loss ............................................. | — | — | — | — | — | (57,788) | (57,788) | |||||||||||
Balance at December 31, 2025 ....... | 279,995 | $1,022,942 | 13,146 | $1 | 375 | $(1,960) | $— | $(244,539) | $(246,498) | |||||||||
(Dollars in thousands) | Year ended December 31, | ||
2025 | 2024 | ||
Cash flows from operating activities: | |||
Net cash used in operating activities ................................................................ | $(31,392) | $(9,483) | |
Cash flows from investing activities: | |||
Investment in subsidiaries ..................................................................................... | (171,243) | (194,437) | |
Other investing activities ...................................................................................... | (2,008) | (176) | |
Net cash used in investing activities ................................................................ | (173,251) | (194,613) | |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock ........................................................... | 492 | 70 | |
Proceeds from issuance of redeemable convertible preferred stock ..................... | 462,000 | 368,343 | |
Issuance costs related to redeemable convertible preferred stock ........................ | (558) | (1,717) | |
Proceeds from issuance of warrants | 6,824 | — | |
Proceeds from issuance of SAFE .......................................................................... | — | 500 | |
Proceeds paid for repurchase treasury shares | (1,943) | — | |
Net cash provided by financing activities ........................................................ | 466,815 | 367,196 | |
Net change in cash and cash equivalents ................................................................... | 262,172 | 163,100 | |
Cash and cash equivalents at beginning of period ..................................................... | 185,761 | 22,661 | |
Cash and cash equivalents at end of period ............................................................... | $447,933 | $185,761 | |
Supplemental disclosure of cash flow information: | |||
Accrued capital expenditures (at end of period) | 151,857 | 20,654 | |
Non- cash contribution to subsidiaries - Remeasurement of redeemable noncontrolling interests in subsidiaries ............................................................. | 12,727 | — | |
Non-cash activity related to conversion of SAFE ................................................ | — | 592 | |
Non-cash activity related to conversion of convertible note ............................... | — | 12,025 | |
(Dollars in thousands) | As of December 31, | ||
2025 | 2024 | ||
Accrued expenses ...................................................................................................... | $6,611 | $2,784 | |
Bonus accrual ............................................................................................................ | 4,830 | 2,591 | |
Deferred grant income ............................................................................................... | 888 | 1,479 | |
Operating lease liabilities .......................................................................................... | 583 | 576 | |
Payroll liabilities ........................................................................................................ | 564 | 74 | |
Total other current liabilities ..................................................................................... | $13,476 | $7,504 | |
Exhibit No. | ||
1.1** | ||
3.1** | ||
3.2 | ||
3.3** | ||
3.4** | ||
4.1** | ||
4.2** | ||
5.1 | ||
10.1†** | ||
10.1(a)†** | ||
10.1(b)†** | ||
10.1(c)†** | ||
10.1(d)†+* * | ||
10.1(e)†+* * | ||
10.2†** | ||
10.2(a)†** | ||
10.2(b)†** | ||
10.3†** | ||
10.4†** | ||
10.5†** | ||
10.6†** | ||
10.7†** | ||
10.8** | ||
10.9+** | ||
10.10+** | ||
10.11+** | ||
10.12+** | ||
10.13+** | ||
10.14+** | ||
10.15+** | ||
10.16+** | ||
10.17** |
Exhibit No. | ||
10.18** | ||
21.1** | ||
23.1 | ||
23.2 | ||
23.3 | ||
24.1** | ||
99.1+** | ||
99.2+** | ||
99.3+** | ||
99.4+** | ||
99.5+** | ||
99.6+** | ||
99.7+** | ||
99.8+** | ||
99.9+** | ||
99.10+** | ||
107 |
FERVO ENERGY COMPANY | |
By: | /s/ Timothy Latimer |
Name: | Timothy Latimer |
Title: | Chief Executive Officer, Chair of the Board |
Signature | Title | |
/s/ Timothy Latimer | Chief Executive Officer (Principal Executive Officer), Director | |
Timothy Latimer | ||
/s/ David Ulrey | Chief Financial Officer (Principal Financial and Accounting Officer) | |
David Ulrey | ||
* | Director | |
Margaret C. Whitman | ||
* | Director | |
Robert Keehan | ||
* | Director | |
Jessica Uhl | ||
* | Director | |
Anne Cleary | ||
* | Director | |
Robert Lowe III | ||
* | Director | |
Ion Yadigaroglu |
*By: | /s/ Timothy Latimer |
Timothy Latimer | |
Attorney-in-Fact |